CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The efficacy and safety of guselkumab as maintenance therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 QUASAR Maintenance Study
DOI 10.1055/s-0044-1789695
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA. Dignaß, D. T. Rubin, J. R. Allegretti, J. Panés, N. Shipitofsky, S. Yarandi, K.-H.G. Huang, M. Germinaro, R. Wilson, H. Zhang, B. G. Feagan, T. Hisamatsu, G. R. Lichtenstein, B. Bressler, L. Peyrin-Biroulet, B. E. Sands
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2024
Jahrgang / SeitenJg. 62 · S. e601-e602
Kernaussage aus der Literatur
Abstract-Vorschau
The efficacy and safety of guselkumab as maintenance therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 QUASAR Maintenance Study
Zitieren
Zitierempfehlung
A. Dignaß, D. T. Rubin, J. R. Allegretti, J. Panés, N. Shipitofsky, S. Yarandi, K.-H.G. Huang, M. Germinaro, R. Wilson, H. Zhang, B. G. Feagan, T. Hisamatsu, G. R. Lichtenstein, B. Bressler, L. Peyrin-Biroulet, B. E. Sands (2024) The efficacy and safety of guselkumab as maintenance therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 QUASAR Maintenance Study. Zeitschrift für Gastroenterologie, 62 (09), e601-e602. https://doi.org/10.1055/s-0044-1789695
Mit CareLit weiterarbeiten